Comparison of Efficacy and Safety Between Propranolol and Steroid for Infantile Hemangioma
Open Access
- 1 June 2017
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Dermatology
- Vol. 153 (6) , 529-536
Abstract
Infantile hemangioma (IH) is the most common tumor of infants and young children.1,2 Although small IH lesions typically do not cause problems, they often require treatment because of the site of occurrence and associated complications such as abnormal eye development or vision problems, airway obstruction, and bowel obstruction.3,4 Historically, steroids have been used as the primary treatment for IH.5,6 Steroids have been shown to be antiangiogenic in a number of in vitro settings and also have shown good therapeutic effects clinically. However, the use of steroids may lead to various complications including gastroesophageal reflux and growth disorders, although these complications are associated with long-term use and high dose.7 A type of anticancer drug or immunomodulator, interferon alfa, may be used for severe IH in cases where patients did not respond to steroids.8,9 However, interferon alfa also has several possible adverse effects, including fever, muscle pain, systemic myalgia, and in severe cases, liver damage, blood toxic effects, thyroid hormonal abnormality, and neurological and neurodevelopmental toxic effects.8 Because of concerns about these adverse effects, many guardians of pediatric patients prefer to wait rather than accept treatment.Keywords
This publication has 40 references indexed in Scilit:
- Propranolol versus captopril in the treatment of infantile hemangioma (IH): A randomized controlled trialJournal of the American Academy of Dermatology, 2016
- Atenolol versus propranolol for the treatment of infantile hemangiomas: A randomized controlled studyJournal of the American Academy of Dermatology, 2014
- Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomaliesBritish Journal of Dermatology, 2014
- Propranolol versus Prednisone in the Treatment of Infantile Hemangiomas: A Retrospective Comparative StudyPediatric Dermatology, 2011
- A Randomized Controlled Trial of Propranolol for Infantile HemangiomasPediatrics, 2011
- Propranolol therapy for infantile haemangiomas: Review of the literatureInternational Journal of Pediatric Otorhinolaryngology, 2010
- Propranolol for Severe Hemangiomas of InfancyNew England Journal of Medicine, 2008
- Prospective Study of Infantile Hemangiomas: Demographic, Prenatal, and Perinatal CharacteristicsThe Journal of Pediatrics, 2007
- Oral Corticosteroid Use Is Effective for Cutaneous HemangiomasArchives of Dermatology, 2001
- Interferon Alfa-2a Therapy for Life-Threatening Hemangiomas of InfancyNew England Journal of Medicine, 1992